The preparation of zaragozic acid A analogues by directed biosynthesis.

Autor: Chen TS; Merck Research Laboratories, Rahway, New Jersey 07065., Petuch B, MacConnell J, White R, Dezeny G, Arison B, Bergstrom JD, Colwell L, Huang L, Monaghan RL

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1994 Nov; Vol. 47 (11), pp. 1290-4.

Improvement in the titer of echinocandin-type antibiotics: a magnesium-limited medium supporting the biphasic production of pneumocandins A0 and B0.

Autor: Tkacz JS; Department of Fermentation Microbiology, Merck Research Laboratories, Rahway, NJ 07065-0900., Giacobbe RA, Monaghan RL

Publikováno v: Journal of industrial microbiology [J Ind Microbiol] 1993 Feb; Vol. 11 (2), pp. 95-103.

L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease. I. The producing organism and its fermentation.

Autor: Dombrowski AW; Department of Microbial Chemotherapeutics and Molecular Genetics, Merck Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065., Bills GF, Sabnis G, Koupal LR, Meyer R, Ondeyka JG, Giacobbe RA, Monaghan RL, Lingham RB

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1992 May; Vol. 45 (5), pp. 671-8.

[R-(Z)]-4-amino-3-chloro-2-pentenedioic acid, a new antibiotic. Fermentation, isolation and characterization.

Autor: Chaiet L, Arison BH, Monaghan RL, Springer JP, Smith JL, Zimmerman SB

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1984 Mar; Vol. 37 (3), pp. 207-10.

Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.

Autor: Goetz MA, Lopez M, Monaghan RL, Chang RS, Lotti VJ, Chen TB

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1985 Dec; Vol. 38 (12), pp. 1633-7.